Suppr超能文献

2007年非黑素瘤皮肤癌的管理

Management of nonmelanoma skin cancer in 2007.

作者信息

Neville Julie A, Welch Erin, Leffell David J

机构信息

Yale University School of Medicine, CT, USA.

出版信息

Nat Clin Pract Oncol. 2007 Aug;4(8):462-9. doi: 10.1038/ncponc0883.

Abstract

As the incidence of nonmelanoma skin cancer (NMSC) increases, so does the number of modalities used to treat this condition. Surgery is the most frequent approach used to treat NMSC, and clinicians usually perform Mohs micrographic surgery, conventional excision, electrodesiccation and curettage or cryosurgery. The 'gold standard' for treatment continues to be Mohs micrographic surgery, but owing to the time and expense involved with this procedure, it is indicated only in patients with aggressive tumors or those where disfigurement or functional impairment is a risk. Although radiation therapy is effective, its use is limited because of the side effects induced; radiation therapy can be used in certain patients who are not surgical candidates. Newer noninvasive options for NMSC include topical chemotherapeutics, biological-immune-response modifiers, retinoids, and photodynamic therapy, which can be used particularly in patients with superficial tumors. Treatments should be tailored to tumor type, location, size, and histological pattern, and although surgical methods remain the most frequently used, newer noninvasive treatments can be used in select tumors and may reduce morbidity.

摘要

随着非黑色素瘤皮肤癌(NMSC)发病率的上升,用于治疗这种疾病的方式数量也在增加。手术是治疗NMSC最常用的方法,临床医生通常进行莫氏显微外科手术、传统切除术、电干燥刮除术或冷冻手术。治疗的“金标准”仍然是莫氏显微外科手术,但由于该手术涉及的时间和费用,仅适用于侵袭性肿瘤患者或有毁容或功能障碍风险的患者。尽管放射治疗有效,但由于其引起的副作用,其应用受到限制;放射治疗可用于某些不适合手术的患者。NMSC较新的非侵入性治疗选择包括局部化疗药物、生物免疫反应调节剂、维甲酸和光动力疗法,这些疗法尤其适用于浅表肿瘤患者。治疗应根据肿瘤类型、位置、大小和组织学模式进行调整,虽然手术方法仍然是最常用的,但较新的非侵入性治疗可用于特定肿瘤,并可能降低发病率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验